Theseus Pharmaceuticals Statistics
Total Valuation
BHE has a market cap or net worth of $1.35 billion. The enterprise value is $1.42 billion.
| Market Cap | 1.35B |
| Enterprise Value | 1.42B |
Important Dates
The last earnings date was Wednesday, July 30, 2025, after market close.
| Earnings Date | Jul 30, 2025 |
| Ex-Dividend Date | Jun 30, 2025 |
Share Statistics
BHE has 35.91 million shares outstanding. The number of shares has increased by 1.31% in one year.
| Current Share Class | 35.91M |
| Shares Outstanding | 35.91M |
| Shares Change (YoY) | +1.31% |
| Shares Change (QoQ) | -0.95% |
| Owned by Insiders (%) | 2.33% |
| Owned by Institutions (%) | 104.40% |
| Float | 35.05M |
Valuation Ratios
The trailing PE ratio is 36.04 and the forward PE ratio is 15.50. BHE's PEG ratio is 0.70.
| PE Ratio | 36.04 |
| Forward PE | 15.50 |
| PS Ratio | 0.52 |
| Forward PS | 0.50 |
| PB Ratio | 1.22 |
| P/TBV Ratio | 1.48 |
| P/FCF Ratio | 16.78 |
| P/OCF Ratio | 11.92 |
| PEG Ratio | 0.70 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.75, with an EV/FCF ratio of 17.59.
| EV / Earnings | 36.96 |
| EV / Sales | 0.55 |
| EV / EBITDA | 9.75 |
| EV / EBIT | 13.61 |
| EV / FCF | 17.59 |
Financial Position
The company has a current ratio of 2.36, with a Debt / Equity ratio of 0.30.
| Current Ratio | 2.36 |
| Quick Ratio | 1.37 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | 1.93 |
| Debt / FCF | 4.09 |
| Interest Coverage | 4.28 |
Financial Efficiency
Return on equity (ROE) is 3.49% and return on invested capital (ROIC) is 4.41%.
| Return on Equity (ROE) | 3.49% |
| Return on Assets (ROA) | 3.12% |
| Return on Invested Capital (ROIC) | 4.41% |
| Return on Capital Employed (ROCE) | 7.25% |
| Revenue Per Employee | $221,259 |
| Profits Per Employee | $3,283 |
| Employee Count | 11,700 |
| Asset Turnover | 1.24 |
| Inventory Turnover | 4.11 |
Taxes
In the past 12 months, BHE has paid $30.86 million in taxes.
| Income Tax | 30.86M |
| Effective Tax Rate | 44.55% |
Stock Price Statistics
The stock price has decreased by -21.22% in the last 52 weeks. The beta is 0.97, so BHE's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | -21.22% |
| 50-Day Moving Average | 38.46 |
| 200-Day Moving Average | 41.44 |
| Relative Strength Index (RSI) | 41.82 |
| Average Volume (20 Days) | 238,661 |
Short Selling Information
The latest short interest is 1.36 million, so 3.79% of the outstanding shares have been sold short.
| Short Interest | 1.36M |
| Short Previous Month | 1.20M |
| Short % of Shares Out | 3.79% |
| Short % of Float | 3.89% |
| Short Ratio (days to cover) | 5.02 |
Income Statement
In the last 12 months, BHE had revenue of $2.59 billion and earned $38.41 million in profits. Earnings per share was $1.05.
| Revenue | 2.59B |
| Gross Profit | 262.62M |
| Operating Income | 104.33M |
| Pretax Income | 87.55M |
| Net Income | 38.41M |
| EBITDA | 145.67M |
| EBIT | 104.33M |
| Earnings Per Share (EPS) | $1.05 |
Balance Sheet
The company has $264.65 million in cash and $330.32 million in debt, giving a net cash position of -$65.68 million or -$1.83 per share.
| Cash & Cash Equivalents | 264.65M |
| Total Debt | 330.32M |
| Net Cash | -65.68M |
| Net Cash Per Share | -$1.83 |
| Equity (Book Value) | 1.11B |
| Book Value Per Share | 30.82 |
| Working Capital | 804.84M |
Cash Flow
In the last 12 months, operating cash flow was $113.63 million and capital expenditures -$32.93 million, giving a free cash flow of $80.70 million.
| Operating Cash Flow | 113.63M |
| Capital Expenditures | -32.93M |
| Free Cash Flow | 80.70M |
| FCF Per Share | $2.25 |
Margins
Gross margin is 10.14%, with operating and profit margins of 4.03% and 1.48%.
| Gross Margin | 10.14% |
| Operating Margin | 4.03% |
| Pretax Margin | 2.68% |
| Profit Margin | 1.48% |
| EBITDA Margin | 5.63% |
| EBIT Margin | 4.03% |
| FCF Margin | 3.12% |
Dividends & Yields
This stock pays an annual dividend of $0.68, which amounts to a dividend yield of 1.80%.
| Dividend Per Share | $0.68 |
| Dividend Yield | 1.80% |
| Dividend Growth (YoY) | 3.03% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 64.98% |
| Buyback Yield | -1.31% |
| Shareholder Yield | 0.49% |
| Earnings Yield | 2.84% |
| FCF Yield | 5.96% |
Analyst Forecast
The average price target for BHE is $47.00, which is 24.64% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $47.00 |
| Price Target Difference | 24.64% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 4, 2006. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Apr 4, 2006 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
BHE has an Altman Z-Score of 3.3 and a Piotroski F-Score of 8.
| Altman Z-Score | 3.3 |
| Piotroski F-Score | 8 |